Hsa-miR-4532 targets the RASD2 gene, which is associated with the canonical pathway’s “insulin receptor signaling”, “TGF-b signaling”, “PPARa/RXRa activation pathway”, and “NF-kB signaling”, all of which have known associations with NAFLD [68,69,70,71,72]. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.